T4
Cardiomyopathies
Inherited cardiomyopathies are heart muscles diseases caused by genetic mutations leading to reduced cardiac pump function, dilatation of the cardiac chambers or thickness of the heart muscle. The progressive nature of the disease requires lifelong monitoring and follow up.
All cardiomyopathies have an increased risk of life-threatening arrhythmias and sudden cardiac death. However, the risk of sudden arrhythmic death does not necessarily coincide with structural progression of disease documented on cardiac imaging studies (echocardiography and cardiac MRI), making risk stratification challenging. Furthermore, risk stratifying tools for finding the correct timing for implanting a prophylactic implantable cardioverter defibrillator (ICD) are missing.
ProCardio is performing extensive and world-leading research in the field of cardiac imaging and arrhythmia prediction in inherited cardiomyopathies.
Projects
- Covid-19 vaccine induced heart inflammation in Norway
- Mutations in the desmoplakin (DSP) gene and arrhythmogenic right ventricular cardiomyopathy (ARVC)
Publications
- Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy
- Distinguishing left ventricular hypertrophy from hypertrophic cardiomyopathy in adolescents: a longitudinal observation study
- Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy
- Reduced cardiac function in a minority of COVID-19 patients
- Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
T4 Teamleader
Nina Eide Hasselberg
Director of Cardiological Research
Consultant Cardiologist, Associated Researcher, MD, PhD